Jeff Johnson
Stock Analyst at Baird
(2.65)
# 580
Out of 5,331 analysts
158
Total ratings
55.32%
Success rate
28.95%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DXCM DexCom | Maintains: Outperform | 115 105 | 81.66 | 28.58% | 14 | May 2, 2025 | |
TNDM Tandem Diabetes Care | Maintains: Neutral | 33 24 | 21.47 | 11.78% | 16 | May 1, 2025 | |
COO Cooper Companies | Maintains: Outperform | 117 107 | 82.23 | 30.12% | 16 | Mar 7, 2025 | |
ALC Alcon | Maintains: Outperform | 104 108 | 98.37 | 9.79% | 9 | Feb 27, 2025 | |
PDCO Patterson Cos | Maintains: Neutral | 25 31 | n/a | n/a | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 22 | 16.96 | 29.72% | 7 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 378 405 | 377.92 | 7.17% | 11 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 325 276 | 179.79 | 53.51% | 16 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 145 | 102 | 42.16% | 13 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 92 82 | 65.28 | 25.61% | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 180 238 | 257.01 | -7.4% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 70 | 35.27 | 98.47% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 53 61 | 14.57 | 318.67% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 67 | 14.09 | 375.51% | 6 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 | n/a | n/a | 7 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 178 | n/a | n/a | 6 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 31 | n/a | n/a | 3 | Nov 11, 2019 |